Cholinergic contraction of canine trachealis muscle, a contraction that primarily utilizes membrane potential-independent mechanisms for activating contractile proteins (pharmacomechanical coupling), is associated with a decline in the phosphatidylinositol pool, an increase in the phosphatidic acid and diacylglycerol pools, and an increased incorporation of 32P04 into phosphatidylinositol. We found that these changes occur during development of the contraction and during maintenance of tension and are independent of membrane depolarization or increases in cytosolic Ca21 concentration. These findings suggest that phosphatidylinositol turnover may be part of a receptor transduction process controlling receptor-operated Ca2+ channels or other membrane potential-independent mechanisms involved in pharmacomechanical coupling in smooth muscle.
Smooth muscle, unlike skeletal or cardiac muscle, can be activated to contract by using mechanisms that are independent of membrane depolarization (1, 2) . The unknown process by which receptor occupancy by an agonist can trigger, in a membrane potential-independent manner, activation of contractile proteins has been termed "pharmacomechanical coupling" (2) . There is scarcely any information about mechanisms involved in such coupling. In some smooth muscles, agonist receptor occupancy can activate both membrane potential-dependent and -independent coupling mechanisms (1). There is evidence for at least two types of plasma membrane Ca2+ channels, a fast potential-dependent channel and a slower, less selective, receptor-operated, potential-independent channel (3, 4) . That pharmacomechanical coupling may be at least partially dependent on extracellular Ca2+ (5, 6) suggests that receptor-operated potential-independent channels may be activated in pharmacomechanical coupling contractions. Devine et al. (7) found that different drugs evoked unequal maximal contractions of the rabbit main pulmonary artery and that unequal contractions persisted when the tissue was bathed in Ca2+-free high-potassium depolarizing solution. This suggests that pharmacomechanical coupling in rabbit main pulmonary artery may involve intracellular Ca2' release. At present, details are not available about relative roles of Ca2+ release or influx or possible effects of altering cytosolic Ca2+-tension relationships during pharmacomechanical coupling contractions.
Numerous studies in nonmuscle tissues indicate that receptor activation of phosphoinositide turnover [the phosphatidylinositol (PtdIns) cycle] might be involved in the transduction of a "signal" between the receptor and a channel or mechanism that is supplying Ca2+ to the cytosol (8) (9) (10) (11) . In this paper we use the term "PtdIns turnover" to indicate the metabolism of phosphoinositides. Recent data indicate that the polyphosphoinositides, phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate, may be in equilibrium with PtdIns, and that the activation of phosphatidylinositol 4,5-bisphosphate diesterase may initiate "turnover" (12) (13) (14) . The phosphoinositide cycle appears to involve the following metabolites: PtdIns, phosphatidylinositol 4-phosphate, phosphatidylinositol 4,5-bisphosphate, diacylglycerol, phosphatidic acid (PtdOH), cytidine diphosphodiacylglycerol, inositol 1,4,5-trisphosphate, inositol 1,4-bisphosphate, inositol 1-phosphate, and inositol (12) (13) (14) . The link between PtdIns turnover and Ca2+ transport or release from internal stores is unknown. Unsaturated diacylglycerol has been shown to be a specific activator of kinase C, which may phosphorylate regulatory enzymes and proteins (15) (16) (17) . PtdOH or inositol 1,4,5-trisphosphate may function in Ca2+ transport or release (18) (19) (20) . Other possible relationships between inositol lipids and membrane function have been discussed by Allan (21) .
The PtdIns cycle has not been completely studied in any smooth muscle. 32P and [3H]inositol labeling experiments and studies in which PtdIns or PtdOH has been measured chemically indicate that PtdIns turnover occurs with activation by various agonists (22) (23) (24) (25) (26) , may parallel development of contraction (22) (23) (24) , and may be independent of both membrane depolarization and increases in cytosolic Ca2+ (22) (23) (24) . To our knowledge, PtdIns turnover has not been previously studied during contraction of smooth muscle activated through pharmacomechanical coupling.
In the present study PtdIns turnover was investigated during a cholinergic muscarinic contraction of canine trachealis muscle. There is previous evidence that this contraction in canine trachealis muscle is dependent on pharmacomechanical coupling mechanisms for activation (5, 6) . New techniques for quantitation of lipids have allowed us precisely to measure phospholipid pool sizes in small quantities of smooth muscle and easily to perform serial measurements of the content of major phospholipids and diacylglycerol during tension development and during the tonic phase of this contraction.
MATERIALS AND METHODS
Preparations. Strips were dissected from the tracheae of mongrel dogs as described (27) , using great care to remove fascia and fat. In six experiments, 5-10 strips weighing a total of 50-500 mg were placed, free floating, in tubes containing 10 ml of medium composed of 137 mM Na+, 5.9 mM K+, 2.5 mM Ca2+, 1.2 mM Mg2+, 134 mM Cl, 1.2 mM H2PO4, In four experiments, 20-to 30-mg single strips were mounted in an organ bath that allowed measurement of isometric tension (27 (32) or with chloroform/methanol (47:3, vol/vol) to 1.5 cm above the origin and hexane/ diethyl ether/acetic acid (62/13/0.75, vol/vol) to the top of the plate (33) . Samples were spotted and the plate was dried under reduced pressure at 250C for 20 min prior to development. After development, plates were dried under reduced pressure at 100'C for 20 min, sprayed with 10% CuS04 in 8% H3PO4 (29) , and charred by successive incubations at 120'C and 170'C. Some 
RESULTS
Carbamoylcholine-induced isometric contractions showed an initial fast phase over the first 50-70 sec resulting in approximately 80% of maximal tension, followed by a slow phase that reached maximal tension after 4-5 min. Tension was then maintained nearly constant for at least 30 min. Thus, the 1-min samples that were analyzed for lipid composition and radioactivity were taken at the end of the rapid contractile phase, whereas the 3-and 5-min analyses gave information during the slow phase and at the time of maximal tension. Fig. 2 shows mechanical effects of 5.5 ,uM carbamoylcholine on canine trachealis muscle tension. Table 1 and Fig. 3 summarize results of the lipid analyses. Phospholipid phosphorus (37) free-floating and isometric experiments, large progressive increases in PtdOH pool size that stoichiometrically paralleled falls in PtdIns during the first 3-5 min. These changes were observed with both mobile phases in charred and phosphorus-stained plates (Fig. 1 ). There were no significant changes in other phospholipids ( (Fig. 3B) . Atropine, 1-10 ,uM, completely inhibited 5.5 ,uM carbamoylcholine contractions, 32p incorporation into PtdIns, and increases in PtdOH and falls in Ptdlns. There was no increase in 32p incorporation into PtdIns (Fig. 3B) Fig. 4 illustrates effects of varying carbamoylcholine contraction on PtdOH increases. .03* The data were obtained by thin-layer chromatography and charring densitometry. Values are expressed as mean ± SD. For free-floating muscle, n = 6; for isometric, n = 4. *P < 0.05 compared to control (calculated only for PtdIns, PtdOH, and diacylglycerol.
tAssuming the molecular weight of diacylglycerol is that of 1,2-dioleoyl glycerol. 
DISCUSSION
The major findings in the present study are the decline in Ptdlns, an increase in PtdOH and diacylglycerol pool sizes, and incorporation of 32P04 into Ptdlns that occurred during development and maintenance of the 5.5 AM carbamoylcholine contraction of canine trachaelis muscle. These findings establish that Ptdlns degradation and resynthesis occur during contraction in a smooth muscle that primarily utilizes membrane potential-independent mechanisms for activating contractile proteins.
Previous data have shown that canine trachealis muscle depolarized with 126 mM K+ contracts on addition of acetylcholine (5). At least 5-10 times more tension development for a given membrane depolarization occurs with acetylcholine compared to that seen with increased extracellular K+ (5). Membrane potential-acetylcholine concentration plots show that incremental drug concentrations greater than 1 ,uM cause additional contraction without further membrane depolarization (6) . Reversal of 5.5 gM acetylcholine-evoked membrane depolarization by current injection does not reverse the contraction, even though a similar procedure completely reverses K+ contractions (5) . That contractions evoked with high acetylcholine concentrations are resistant to Ca2' entry blockers (5, 6) in this muscle as well as in other airway smooth muscle (38) suggests that membrane potential-dependent Ca2+ channels are of small importance in these contractions. Thus, it seems established that at least the tonic phase of 5.5 ,uM acetylcholine contractions is dependent on pharmacomechanical coupling mechanisms.
Although cholinergic contractions of canine trachealis muscle may not be mediated entirely by pharmacomechanical coupling mechanisms, the demonstration in this study that It was possible, using our sensitive techniques of lipid analysis, to study lipid metabolism in single smooth muscle strips held under known mechanical conditions. Comparison of data obtained by using the free-floating and isometric preparations suggests that the amount of stretch or whether the strip contracts isotonically or isometrically may not markedly influence PtdIns turnover.
Our experiments were designed to determine if PtdIns turnover occurs during development and maintenance of a pharmacomechanical coupling contractions and we did not measure, in this series of experiments, changes in polyphosphoinositides or inositol phosphates. Such measurements in smooth muscle would, of course, be of great interest because these metabolites may function as second messengers (19, 20) . The 6.5-to 7.7-fold increase in PtdOH pool size (3-to 5-min carbamoylcholine exposures) implies a rapid rise in membrane concentrations of this lipid, which could then elicit effects on membrane proteins, Ca2+ transport, or Ca2+-tension relationships. However, the increase in PtdOH pool may reflect, in part, increases in PtdOH in the endoplasmic reticulum as a result of transfer from the plasma membrane. The 
